Ultra-fast insulin drug Fiasp to be removed from PBS making it unaffordable for many diabetes sufferers
in by Hospital + Health | Hospital Equipment and Medical Products Suppliers Directory 0 Reviews
For the past six months, 14-year-old Freya Goldston has attended more school, swimming training and increased her time with friends — but that quality of life is now at risk. Fiasp, the ultra-fast insulin she relies on to treat her type 1 diabetes will be taken off the Pharmaceutical Benefits Scheme (PBS) next month, sending the price...
Read More